徐州孕7个月四维b超徐州怀孕多久可以测出来,徐州四维彩超成像还是黑白的,徐州哪家四维彩超便宜,徐州妇产科大夫,徐州哪家医院可以做四维彩超,徐州四维五个月做吗,徐州做四维彩超需要多少钱

SAN DIEGO (KGTV) -- Many families throughout San Diego County are struggling due to the coronavirus pandemic, making the otherwise cheery holiday season less than ideal.Despite hard economic times, many throughout the region are finding ways to give back in 2020.Although volunteering may look different this year, there are plenty of opportunities to help out, from donating to food banks to fostering an animal.Feeding San DiegoNot only can you donate to help feed families, students, and seniors in need through Feeding San Diego, but your help also keeps the group's food distributions running and supports mobile pantries.And with ABC 10News, you can help us provide millions of meals to San Diegans during our Month of a Million Meals through Dec. 31. Last year, the campaign raised more than 5.1 million meals. Learn how you can help here.San Diego Food BankThe San Diego Food Bank has more than doubled the number of people it’s providing food assistance to during COVID-19. From mid-March through October, the organization distributed more than 37 million pounds of food. The food bank says all volunteer shifts have been booked through the fall, but you can still sign up to volunteer at a later date here. You can also donate money. The organization says for every given, 5 meals can be provided.Father Joe's VillagesHelp support Father Joe's Villages and provide aid to individuals battling homelessness in San Diego. Donations can help provide housing, meals, health care, and education to those in need locally. Anyone interested can donate money, goods, a vehicle, or their time to help. Learn more about how to help.The Salvation ArmyIt wouldn’t be Christmas without the famous Red Kettles. However, this year, the organization is taking its campaign online. With a few mouse clicks, you can help the Salvation Army support bill assistance, homeless shelters, and food pantries across San Diego. To donate to the Red Kettle Campaign online here.And despite the pandemic, The Salvation Army is asking volunteers to answer the call and become a Christmas Kettle Bell Ringer. Click here to sign up.San Diego Humane SocietyThe Humane Society has temporarily suspended its volunteer recruitment and onboarding due to the coronavirus, but that doesn’t mean you can’t give back. The organization is still accepting donations. Donations will help the group provide medical care, shelter, and food to homeless animals. Of course, pet adoptions are still running this season as well. You can also sign up to foster a pet. Visit the humane society's website to learn how to adopt or foster a pet, or donate.Red Cross San DiegoYou can also help the Red Cross San Diego's humanitarian and disaster relief efforts for those in need. Donations with help support safe shelters, hot meals, care, and comfort for people who have lost everything to a disaster.The Red Cross is also supporting the critical need for blood during this time. Click here to learn how you can donate blood.San Diego Blood BankThe San Diego Blood Bank is in need of volunteers to donate blood, especially during the holiday season. The bank aims to collect more than 350 units of blood each day in order to meet the needs of local patients who are battling life-threatening conditions. One pint of blood can save up to three lives. You can sign up for an appointment here. 3357

SAN DIEGO (KGTV) - Jo Anne Bilodeau finds peace inside the grounds of her serene San Carlos apartment complex, filled with greenery, benches, a clubhouse and a pool.Even her rent is less than ,100 a month. "It kind of feels like a sanctuary," she says. But Bilodeau's days in San Diego could be numbered, all because of a specialty shot she takes every 12 weeks. RELATED: Making It in San Diego: Prescription medication costs impacting San Diego families"It's just scary," Bilodeau says. "It makes you feel like you're in limbo all the time because you don't know the exact cost of the drug until you get a bill."Bilodeau suffers from Rheumatoid Arthritis, an autoimmune disease that causes the body to mistakenly attack the joints. She's about to turn 71 and on medical leave from her job, meaning her company health benefits are expiring. That leaves her with just Medicare, and what she believes will be a ,300 co-insurance payment on the drug."I have my days," she says. "I have meltdowns where I just cry because I'm worried and scared."Bilodeau isn't the only one with that anxiety.A new study by AARP says the price for specialty prescription drugs, ones that are generally infused or injected, rose 7 percent in 2017. That's more than three times the rate of inflation. The average annual cost for these drugs is nearly ,000. RELATED: Making It in San Diego: How to save money on your prescriptions"The prices for those medications has risen dramatically," said Leslie Ritter, a senior director at the National Multiple Sclerosis society, a condition that also requires specialty drugs.Ritter says patients on the medications have skipped doses and racked up credit card debt. "Medications only work if you're adhering to them, and you're taking them as prescribed," she says. Federal and State governments are now moving legislation to help lower prices and increase transparency. In the meantime, Leigh Purvis, of the AARP Public Policy Institute, said the best thing to do is for patients to talk to their health care providers to see if there is a less expensive generic alternative to treat the same condition.Drug manufacturers themselves also offer patient assistance programs to those who are eligible. However, they are only available to privately and commercially insured patients, not those on Medicare. 2338

SAN DIEGO (KGTV) — In just days, Pfizer’s COVID-19 vaccine will go before a key group of scientific advisers to the Food and Drug Administration, and a San Diego doctor will be part of the process to cast an important vote.Dr. Mark Sawyer, an infectious disease specialist at Rady Children’s Hospital, will serve as a voting member of the Vaccines and Related Biological Products Advisory Committee or VRBPAC when the body meets Dec. 10 to publicly vet Pfizer’s COVID-19 candidate.Dr. Sawyer is also a professor of clinical pediatrics at UC San Diego. He has served before on this outside advisory committee to the FDA, but the stakes have never been so high.“I mean this is a tough decision,” he said in an interview Friday. “We're weighing the benefit of a vaccine against the risks. And with any new product, we don't know the risks and we have to estimate based on the data we have.”Dr. Sawyer said he received Pfizer’s full Phase 3 data Friday morning, making him one of the first Americans outside the FDA to see the full details of the company’s large-scale clinical trial. The FDA is expected to release the data to the general public by Tuesday, two days before the public meeting.Sawyer will be one of about 20 outside vaccine experts from around the country on VRBPAC. The FDA hasn’t yet released a full roster of the doctors and scientists who will take part. The independent advisory committee will hear comments from Pfizer and the FDA and listen to public input before voting on whether to recommend emergency authorization.The marathon meeting is expected to last up to nine hours.“The FDA counts on this advisory committee to be an independent group of people who are looking at the same information they looked at and asking us what our concerns are, or whether we reached the same conclusion that their staff have reached,” he said.The meeting comes on the heels of a study by Pew Research that found lingering skepticism of the vaccine. Just 60% of Americans planned to get vaccinated as of the survey released Monday.“I do think that's going to change once this committee meets and the data is made public and we can all talk together as a community about what we know about the safety, and what we don't know, frankly,” he said.Dr. Sawyer was a member of VRBPAC for four years and briefly served as the acting chair in 2017.The committee meets a few times each year to make recommendations on the annual flu vaccine and other drugs.The committee’s vote is not binding. The job of the outside advisers is to issue a recommendation and the FDA can overrule them, but the agency rarely does. From 2003 to 2019, VRBPAC made 105 recommendations. The agency fully implemented 84% of VRBPAC’s recommendations and partially implemented 10%, according to Union of Concerned Scientists.That means when the committee votes Thursday, it’ll carry a lot of weight. The FDA is expected to announce its final decision shortly after the vote, possibly within hours.Dr. Sawyer said the advisers will make a decision following the process they traditionally do, based on all the knowns and unknowns. “And we’re going to weigh that against what we're going through right now,” he said. “Our hospitals are getting overwhelmed. Our ICUs are getting full.”“We really need to do something to intervene and the vaccine is the best thing we've got going,” he added. 3369

SAN DIEGO (KGTV) — It’s one of the few drugs shown to help fight the novel coronavirus, and a large federal study on remdesivir just entered a new phase.Previous research sponsored by the National Institute for Allergy and Infectious Disease showed remdesivir shortened recovery time in hospitalized COVID-19 patients on average from 15 days to 11 days.Now scientists and doctors are racing to find the perfect cocktail against COVD-19 by blending remdesivir with other drugs.California-based Gilead Sciences originally developed the drug to fight Ebola, but remdesivir was never approved. Gilead Sciences has offices in Oceanside.The drug works by interrupting the virus’ ability to replicate.“Remdesivir acts by shutting down virus production,” said Dr. Peter Chin-Hong, an infectious disease expert at University of California San Francisco. “It just forces the virus to stop making virus children.”Dr. Chin-Hong is studying remdesivir as part of the NIAID research.The problem is that stopping the virus from replicating isn’t enough for some severely ill patients. They suffer from a second problem: massive inflammation from the immune system’s war with the virus.That’s why scientists are trying a cocktail approach.“You have the virus to take care of, but you also have the body's response to the virus, which is inflammation, that you also have to take care of,” said Dr. Chin-Hong.Researchers started testing the first drug cocktail in May, using an arthritis drug called baricitinib that tames inflammation.But as the data on that part of the study gets crunched, researchers began testing the second cocktail this month, a combination of remdesivir and interferon beta.“Interferon beta is something we produce naturally to fight viruses,” said Dr. Chin-Hong. He said studies have shown people who don’t produce enough interferon beta struggle to fight off the virus.Researchers selected interferon beta after two small studies showed promising results against the coronavirus.Interferon beta can both reduce inflammation and kill viruses, so doctors are hoping it will be a potent one-two punch with remdesivir.Dr. Chin-Hong said he and other researchers started administering the new cocktail this month.Some patients will receive the cocktail, some will receive a placebo, and some will get remdesivir only. This kind of clinical trial is called an adaptive trial, which the FDA started encouraging in 2004. After each phase, the winning drug or cocktail will be tested against a new challenger.Dr. Chin-Hong said the eventual cocktail may include three or more drugs, similar to HIV medication. 2617

SAN DIEGO (KGTV) -- It’s Safely Back to School week on ABC 10News and we’re talking about issues that impact education during this pandemic.As part of our ABC 10News San Diego Back to School Safely week, anchor Ben Higgins talked with local expert Lisa Smith, a parent coach, with advice on how to calm the chaos in your home. 334